CARM
$0.05 0.00 (0.00%)
Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
March 8, 2023$0.362023-03-082023-03-07

Dividends Summary

Company News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders
GlobeNewswire Inc. • Halper Sadeh Llc • July 26, 2025

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers or sales transactions.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders
Benzinga • Prnewswire • July 16, 2025

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches related to merger and sale transactions involving NV5 Global, Carisma Therapeutics, and Heliogen.

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY
Benzinga • Juan Monteverde • July 15, 2025

Law firm Monteverde & Associates is investigating potential legal actions related to merger transactions involving four companies: 180 Degree Capital, Heliogen, Carisma Therapeutics, and Guaranty Bancshares.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, CARM, ENZB on Behalf of Shareholders
GlobeNewswire Inc. • Halper Sadeh Llc • July 5, 2025

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies, including Couchbase, Carisma Therapeutics, and Enzo Biochem, related to their recent sales or merger transactions.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, BASE, CARM, ENZB on Behalf of Shareholders
Benzinga • Prnewswire • July 1, 2025

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for GMS, Couchbase, Carisma Therapeutics, and Enzo Biochem related to their recent merger or sale transactions.

Related Companies